Tens of thousands of patients could benefit from a ‘rapid’ new immunotherapy jab on the NHS for over a dozen different cancers, which can be given in just 60 seconds. The NHS is rolling out a new ...

This section contains statistics relating to the activity of NHS Continuing Healthcare and NHS-funded Nursing Care in England. Categories of activity covered are: eligibility, referrals, conversion ...

Clinical audit is a way to find out if healthcare is being provided in line with standards and lets care providers and patients know where their service is doing well, and where there could be ...

Revisions are published periodically (usually every six months) in line with NHS England Analytical Service team’s revisions policy. Referral to treatment data for October 2024 to March 2025 was ...

NHS England » Implementing the 2026/27 GP Contract changes to personal medical services and alternative provider medical services contracts ...

The general medical services (GMS) and primary care network (PCN) – practice and PCN income ready reckoner for 2026/27.

The Monthly A&E Attendances and Emergency Admissions collection collects the total number of attendances in the calendar month for all A&E types, including Minor Injury Units and Walk-in Centres, and ...

More than 1,000 NHS staff across England have used Martha’s Rule helplines to help identify rapid deterioration of a patient’s condition in the first 18 months of the scheme, new figures show.

NHS England — South West NHS England — South West is one of the seven regional teams covering the counties of Bath, Wiltshire, West Bristol, Somerset, Gloucestershire, Cornwall and Isles of Scilly, ...

Responsibility for Armed Forces healthcare is split between the Ministry of Defence (MOD) and the NHS. Defence Medical services (DMS) provide a range of services for regular serving personnel in the ...

Hospital patients at every NHS trust across England can now check their referrals and appointments through the NHS App, making it easier for millions of people to manage their car ...

Neoadjuvant followed by adjuvant pembrolizumab is recommended to be available as a routine commissioning treatment option for stage III macroscopic resectable melanoma within the criteria set out in ...